Search - tctmd.com

Displaying 361 - 380 of 620

Sort: Relevancy | Date

Presentation TCT 2018

Flash Debate #2: Impella Is the Optimal Support Platform for Cardiogenic Shock

Presenter: Vladimir Dzavik, Richard Smalling, Perwaiz M. Meraj

September 24, 2018

Presentation TCT 2018

Flash Debate #2: VA-ECMO Is the Optimal Support Platform for Cardiogenic Shock

Presenter: Vladimir Dzavik, Richard Smalling, Michael Mooney

September 24, 2018

Presentation TCT 2018

Hub and Spoke Strategies for Cardiogenic Shock: What are the Essential Elements?

Presenter: Vladimir Dzavik, Richard Smalling, Holger Thiele

September 24, 2018

Presentation TCT 2018

Using Hemodynamics to Guide Decision-Making in Cardiogenic Shock

Presenter: Vladimir Dzavik, Richard Smalling, Salvatore F Mannino

September 24, 2018

Presentation TCT 2018

Hemodynamic Support: Which Device for Which Patient and Why?

Presenter: Vladimir Dzavik, Richard Smalling, Daniel Burkhoff

September 24, 2018

Presentation TCT 2018

What Interventionalist Should Know About Using ECMO-Assisted Coronary Intervention in Cardiogenic Shock

Presenter: Michael Kang-Yin Lee, Ivo Petrov, Marin Postu, Zoltan Ruzsa

September 24, 2018

Presentation TCT 2018

Defining Cardiogenic Shock for 2018 and the Future: Hemodynamic vs Hemometabolic Shock

Presenter: Vladimir Dzavik, Richard Smalling, Navin K. Kapur

September 24, 2018

Presentation TCT 2018

Case Presentation #2: A High-Risk, Complex Patient With STEMI and Multivessel Disease

Presenter: Anthony H. Gershlick, Pieter C. Smits, Marwan F. Jumean

September 24, 2018

Presentation TCT 2018

Flash Debate #1: Based on What We Dont Know - Culprit Lesion Only PCI With a Conservative Approach Is the Preferred Strategy!

Presenter: Anthony H. Gershlick, Pieter C. Smits, Deepak L. Bhatt

September 24, 2018

Presentation TCT 2018

Flash Debate #1: Based on What We Know - Routine Multivessel Revascularization (Acute or Delayed) Is the Preferred Strategy!

Presenter: Anthony H. Gershlick, Pieter C. Smits, Thomas Engstrøm

September 24, 2018

Presentation TCT 2018

The Role of FFR, iFR, and iMR in Assessing Non-Culprit Lesions and Vessels in STEMI

Presenter: Anthony H. Gershlick, Pieter C. Smits, Joo Myung Lee

September 24, 2018

Presentation TCT 2018

Management of Non-Culprit CTO in STEMI

Presenter: Anthony H. Gershlick, Pieter C. Smits, Emmanouil S. Brilakis

September 24, 2018

Presentation TCT 2018

Rationale and Data for Multivessel PCI in STEMI

Presenter: Anthony H. Gershlick, Pieter C. Smits

September 24, 2018

Presentation TCT 2018

Mechanisms and Treatment Options for MINOCA

Presenter: Morton J. Kern, Graham Nichol, Francesco Pelliccia

September 24, 2018

Presentation TCT 2018

Devices to Reduce Infarct Size in STEMI

Presenter: Morton J. Kern, Graham Nichol, Gregg W. Stone

September 24, 2018

Presentation TCT 2018

Case Presentation #1: No Reflow After Primary PCI

Presenter: Morton J. Kern, Graham Nichol, Sorin J. Brener, Rajiv Gulati, Neal S. Kleiman, Dharam J. Kumbhani, Divaka Perera, Marco A. Perin

September 24, 2018

Presentation TCT 2018

Recognition, Diagnosis, and Management of Spontaneous Coronary Artery Dissection

Presenter: Morton J. Kern, Graham Nichol, Jacqueline Saw

September 24, 2018

Presentation TCT 2018

The Role of FFR, iFR, iMR, and WIA In Evaluating Culprit Lesion and Vessel Flow In STEMI

Presenter: Morton J. Kern, Graham Nichol, Kalpa De Silva

September 24, 2018

Presentation TCT 2018

Device Versus Drug-Based Approaches to Limit No Reflow In STEMI

Presenter: Morton J. Kern, Graham Nichol, Mauricio G. Cohen

September 24, 2018

Presentation TCT 2018

Spain Discusses: How Would I Approach This Patient (and Cardiogenic Shock in General)?

Presenter: David W.M. Muller, Armando Perez de Prado, Niels van Royen, Raul Moreno

September 23, 2018

Advertisement

Flash Debate #2: Impella Is the Optimal Support Platform for Cardiogenic Shock

Flash Debate #2: VA-ECMO Is the Optimal Support Platform for Cardiogenic Shock

Hub and Spoke Strategies for Cardiogenic Shock: What are the Essential Elements?

Using Hemodynamics to Guide Decision-Making in Cardiogenic Shock

Hemodynamic Support: Which Device for Which Patient and Why?

What Interventionalist Should Know About Using ECMO-Assisted Coronary Intervention in Cardiogenic Shock

Defining Cardiogenic Shock for 2018 and the Future: Hemodynamic vs Hemometabolic Shock

Case Presentation #2: A High-Risk, Complex Patient With STEMI and Multivessel Disease

Flash Debate #1: Based on What We Dont Know - Culprit Lesion Only PCI With a Conservative Approach Is the Preferred Strategy!

Flash Debate #1: Based on What We Know - Routine Multivessel Revascularization (Acute or Delayed) Is the Preferred Strategy!

The Role of FFR, iFR, and iMR in Assessing Non-Culprit Lesions and Vessels in STEMI

Management of Non-Culprit CTO in STEMI

Rationale and Data for Multivessel PCI in STEMI

Mechanisms and Treatment Options for MINOCA

Devices to Reduce Infarct Size in STEMI

Case Presentation #1: No Reflow After Primary PCI

Recognition, Diagnosis, and Management of Spontaneous Coronary Artery Dissection

The Role of FFR, iFR, iMR, and WIA In Evaluating Culprit Lesion and Vessel Flow In STEMI

Device Versus Drug-Based Approaches to Limit No Reflow In STEMI

Spain Discusses: How Would I Approach This Patient (and Cardiogenic Shock in General)?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content